How Long Will I Need to Be on GLP-1 for Weight Loss
Iwaya H, Kashiwaya M, Shinoki A, Lee JS, Hayashi K, Hara H et al
Other peptides, including AOD-9604, Retatrutide, CJC-1295, and MOTS-c, either have limited evidence or are still being studied
Cost-effectiveness also favors monotherapy
Emerging Frontiers in GLP-1 Therapeutics: A Comprehensive Evidence Base (2025)
Another study in over 78 000 women without kidney stone disease found that higher dietary calcium was associated with a 528% reduction in kidney stone risk, and a study in over 96 000 younger women without kidney stones found that those in the highest one-fifth of dietary calcium consumption had a 27% lower risk of kidney stones compared with those in the lowest one-fifth (Sorensen, Kahn 2012